GC Biopharma Corp.

ACTIVE

107 Ihyeon-ro 30beon-gil, Giheung-gu, Yongin, Gyeonggi, South Koreawww.greencross.comPrivate1,001–5,000 employees

Also known as:

gc biopharma corp._eumseong plant

gc biopharma corp._ochang plant

Clinical Trials

6 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

53.3%

Phase 3

26.7%

Not Applicable

6.7%

Trial Status Distribution

Active, not recruiting

33.3%

Completed

13.3%

Not yet recruiting

6.7%

Recruiting

46.7%

Clinical Trials

Trials sponsored by this organization (15)

A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years

Phase 3

Recruiting

interventional

Mar 2026474 participants

A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults

Phase 1

Active, not recruiting

interventional

Jan 202672 participants

A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults

Phase 1

Recruiting

interventional

Jun 2025120 participants

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

Phase 1

Recruiting

interventional

May 202518 participants

Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)

Phase 1

Active, not recruiting

interventional

Nov 20249 participants

Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study

Active, not recruiting

observational

Jun 20231,563 participants

A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.

Phase 3

Recruiting

interventional

Apr 2023105 participants

A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions

Phase 1

Recruiting

interventional

Feb 202334 participants

Page 1 of 2

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

Approvals

PHILIPPINES

Philippines FDA

Approvals

NPRA

National Pharmaceutical Regulatory Agency

Approvals

Recent Approvals

I.V.-Globulin SN-JAKEL 100mg/ml Solution for Injection

NPRA

2026-08-07

Hunterase 2mg/mL Solution for Injection

NPRA

2025-11-28

Albumin-GCC-JAKEL 20% Solution for Injection

NPRA

2025-11-28

I.V.-Globulin SN-JAKEL 50mg/ml Solution for Injection

I.V.-Globulin SN Inj. (50mg/mL)

NPRA

2025-11-28

HEPABIG INJECTION (1ML VIAL)

News

No news articles found

Back to Organizations